Inventor
Jon J. Hangeland
Inventor
Morrisville, PA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes21%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium12%
C07CAcyclic or carbocyclic compounds8%
C07HSugars1%
PatentTitleYear
10,966,967Aryl dihydropyridinones and piperidinone MGAT2 inhibitors202110,695,328Aryl dihydropyridinones and piperidinone MGAT2 inhibitors202010,369,140Aryl dihydropyridinones and piperidinone MGAT2 inhibitors201910,112,936Five-membered heterocycles useful as serine protease inhibitors20189,901,572'Aryl dihydropyridinones and piperidinone MGAT2 inhibitors'20189,663,466'Aryl dihydropyridinones and piperidinone MGAT2 inhibitors'20179,617,224'Five-membered heterocycles useful as serine protease inhibitors'20179,493,412'Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors'20169,249,096'Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors'20169,187,424'Aryl dihydropyridinones and piperidinone MGAT2 inhibitors'20159,120,794'Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors'20159,079,860'Five-membered heterocycles useful as serine protease inhibitors'20158,952,180'Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors'20158,791,091'Aryl dihydropyridinone and piperidinone MGAT2 inhibitors'20148,716,492'Five-membered heterocycles useful as serine protease inhibitors'20148,263,659'Thyroid receptor ligands'20128,101,778'Five-membered heterocycles useful as serine protease inhibitors'20127,709,646'Tetrahydroquinoline derivatives useful as serine protease inhibitors'20107,557,143'Thyroid receptor ligands'20097,504,431'Sulfonyl amide inhibitors of calcium channel function'20097,453,002'Five-membered heterocycles useful as serine protease inhibitors'20087,429,604'Six-membered heterocycles useful as serine protease inhibitors'20087,288,571'Thyroid receptor ligands and method II'20077,138,412'Tetrahydroquinoline derivatives useful as serine protease inhibitors'20066,989,402'Thyroid receptor ligands and method II'20066,951,844'Phenyl naphthol ligands for thyroid hormone receptor'20056,831,102'Phenyl naphthol ligands for thyroid hormone receptor'20046,747,048'Pyridine-based thyroid receptor ligands'20045,994,517'Ligands to enhance cellular uptake of biomolecules'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2021Based in Morrisville, PA, US· patent location history
2004–2021Patents assigned to BRISTOL MYERS SQUIBB CO (26)· patent assignee history
2012–2014Patents assigned to FRIENDS TODD J (3)· patent assignee history
2012–2014Patents assigned to HANGELAND JON J (3)· patent assignee history
2012–2014Patents assigned to BISACCHI GREGORY S (2)· patent assignee history
2012–2014Patents assigned to CAVALLARO CULLEN L (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 26 | 2004–2021 |
| FRIENDS TODD J | 3 | 2012–2014 |
| HANGELAND JON Jself | 3 | 2012–2014 |
| BISACCHI GREGORY S | 2 | 2012–2014 |
| CAVALLARO CULLEN L | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Morrisville, Pennsylvania, US | 29 | 1999–2021 |